( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
161.72
128.89
110.81
169.53
Total Expenditure
200.97
152.31
134.11
255.08
PBIDT (Excl OI)
-39.25
-23.42
-23.3
-85.55
Other Income
66.97
77.43
65.37
57.41
Operating Profit
27.71
54.01
42.06
-28.14
Interest
10.87
9.47
11.02
15.33
Exceptional Items
NA
NA
NA
NA
PBDT
16.84
44.54
31.04
-43.47
Depreciation
14.1
14.59
14.17
16.33
Profit Before Tax
2.73
29.95
16.87
-59.8
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
2.19
18.95
12.84
-95.27
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
2.19
18.95
12.84
-95.27
Minority Interest
NA
NA
NA
NA
Shares of Associates
4.07
4.5
-1.35
7.68
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
6.27
23.45
11.49
-87.59
Equity Capital
129.7
118
118
118
Face Value (IN RS)
10
10
10
10
Calculated EPS
0.48
1.98
0.97
-7.42
Calculated EPS (Annualised)
1.93
7.94
3.89
-29.69
No of Public Share Holdings
6835665
5665665
5665665
5665665
% of Public Share Holdings
52.7
48.01
48.01
48.01
PBIDTM% (Excl OI)
-24.27
-18.17
-21.02
-50.46
PBIDTM%
17.13
41.90
37.95
-16.59
PBDTM%
10.41
34.55
28.01
-25.64
PBTM%
1.69
23.23
15.22
-35.27
PATM%
1.36
14.70
11.58
-56.19